Methotrexate

Therapeutics

Brands

• Amethopterin, Emthexate, Ledertrexate, Maxtrex, Mexate, MTX, Trexall, Rheumatrex, Metoject

Generic?

Yes

Class

• Folic acid antagonist, immunomodulator

Commonly Prescribed for

(FDA approved in bold)

• Treatment of malignancies, including non-Hodgkin lymphoma, gestational choriocarcinoma, head and neck epidermoid cancer, and lung and breast cancer

• Psoriasis

• Rheumatoid arthritis

• Inflammatory myopathies: polymyositis (PM) and dermatomyositis (DM)

• Vasculitis, including Wegener's granulomatosis

• Relapsing-remitting or chronic progressive multiple sclerosis (MS)

• Ulcerative colitis or Crohn's disease

• Systemic lupus erythematosus

• Psoriatic arthritis

How the Drug Works

• Inhibits dihydrofolic acid reductase. Prevents synthesis of purine nucleotides and thymodylate. This interferes with DNA synthesis, repair, and replication

How Long Until It Works

• Within a week, but effect on neurological diseases may take months

If It Works

• DM/PM: improves strength, and may allow discontinuation or reduced dose of corticosteroids. Corticosteroids are tapered first. Taper slowly over 6 months if clinical remission occurs

• MS: May reduce relapses and new lesions on MRI

• Other disorders: Improves symptoms and clinical markers of the disease

If It Doesn't Work

• DM/PM: Question the diagnosis (inclusion-body myositis, hypothyroidism, muscular dystrophy), rule out corticosteroid-induced myopathy, and evaluate for undiagnosed malignancy (especially in DM). Change to azathioprine

• MS: If clearly not helpful, change to another agent

Best Augmenting Combos for Partial Response or Treatment-Resistance

• Usually used in combination with corticosteroids (to reduce corticosteroid dose) in DM and PM. Occasionally combined with other treatments for the treatment of MS

Tests

• Obtain CBC, liver and renal function tests, and chest x-ray at baseline and at dosage adjustments, or for any clinical symptoms. Use serum level and WBC to assess response to treatment

Current Prices for Individual Subscribers (prices are subject to change)

	Pay-per-view Subscription (48 hours)	Unit price
Subscribe	Stahl's Essential Psychopharmacology Online Revised and Updated Edition 3rd Edition ISBN: 9780511447990	$ 40
	Annual Subscription (Single User)	Unit price
Subscribe	Stahl's Essential Psychopharmacology Online Revised and Updated Edition 3rd Edition ISBN: 9780511447983	$ 195
	Print + Online Access (One Year, Single User)	Unit price
Purchase	Stahl's Essential Psychopharmacology Online Digital Edition: Print and Online Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org. ISBN: 9780521746090	$261

For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

Stahl's Essential Psychopharmacology Online

Navigation